This study was undertaken to determine the minimum CBF and CMR07 required by the human brain to maintain normal functio-n and viability for more than a few hours. Positron emission tomography (PET) was used to perform regional measurements in 50 subjects with varying degrees of cerebral ischemia but no evidence of infarction. There were 24 normal subjects, 24 subjects with arteriographic evidence of vascular disease of the carotid system, and two subjects with reversible ischemic neurological deficits due to cerebral vasospasm. Min imum values found in the 48 subjects with normal neu rological function were 19 mi/IOO g-min for regional ce rebral blood flow (rCBF) and 1.3 mi/IOO g-min for re gional cerebral metabolic rate of oxygen (rCMROJ). Minimum values for all 50 subjects with viable cerebral tissue were 15 ml/IOO g-min for rCBF and 1.3 mi/IOO gcerebral blood volume; rCMR g 1u, regional cerebral metabolic rate of glu cose; rCMR02, regional cerebral metabolic rate of oxygen; RIND, reversible ischemic neurological deficits; rOEF, regional oxygen extraction fraction.
Measurements of regional cerebral blood flow (reB F) in experimental animals subjected to focal cerebral ischemia have demonstrated the existence of two separate thresholds for ischemic neuronal damage. Electrocerebral activity diminishes at flows below 20 mlllOO g-min, whereas membrane failure and cell death do not occur until reBF falls below �10 mlllOO g-min (Jones et aI. , 198 1; Astrup, 1982; Heiss and Rosner, 1983; Branston et aI. , 1984) . Values for reBF within this range of 10-20 mlllOO g-min have been correlated with reversible min for rCMR02• Comparison of these measurements with values from 20 areas of established cerebral infarc tion in 10 subjects demonstrated that 80% (16/20) of in farcted regions had rCMR02 values below the lower normal limit of 1.3 ml/IOO g-min. Measurements of rCBF, regional cerebral blood volume, and oxygen extraction fraction were less useful for distinguishing viable from infarcted tissue. These data indicate that quantitative re gional measurements of rCMROJ with PET accurately distinguish viable from nonviable cerebral tissue and may be useful in the prospective identification of patients with reversible ischemia. Key Words: Cerebral blood flow Cerebral infarction-Cerebral ischemia-Cerebral ox ygen metabolism-Cerebrovascular disease-Positron emission tomography.
neurological deficits in an experimental study of ce rebral ischemia in primates (Jones et aI. , 198 1) . Sim ilar studies of ischemic thresholds in humans have been primarily restricted to establishing the rela tionship between reBF and electroencephalo graphic (EEG) changes in patients undergoing ca rotid endarterectomy. These studies have demon strated a threshold of 17-18 mlll00 g-min for changes in electrocerebral activity (Leech et aI. , 1973; Tr ojaborg and Boysen, 1973; Sundt et aI. , 1974) . All of these studies have employed acute re ductions in cerebral blood flow lasting from minutes to a few hours. The degree to which the human brain can tolerate more gradual development of ischemia or more prolonged duration of milder de grees of ischemia is not known. Such knowledge is of particular clinical relevance, as patients with acute ischemic stroke are rarely hospitalized during the first few hours. Therefore, any intervention to salvage ischemic tissue must take place after this period.
More recently, it has become evident that the re sponse of cerebral neurons to short-term ischemia is too complex to be described by simple threshold concepts. The degree of ultimate neuronal damage depends not only on the magnitude of the rCBF reduction but also on the duration of the insult, the selective vulnerability of specific neuronal popula tions, and a wide variety of other factors, including antecedent cerebral glucose stores (Myers and Ya maguchi, 1977; Jones et aI. , 198 1; Astrup, 1982; Marcoux et aI., 1982; Garcia et aI. , 1983; Heiss and Rosner, 1983; Raichle, 1983) . Given the normal de pendence of brain on the oxidative metabolism of glucose, it is likely that regional cerebral metabolic rate of oxygen (rCMR02) or glucose (rCMR g 1u) may be important determinants of cerebral function and viability.
The development of positron emission tomog raphy (PET) has made it practical to perform ac curate, quantitative regional measurements of CBF and metabolism in humans. The diagnostic accu racy of PET for distinguishing between reversibly ischemic and irreversibly infarcted tissue in any in dividual patient will depend on the amount of overlap among the values found in normal, isch emic, and infarcted regions. Methodological inac curacies, partial volume averaging, biological vari ability, and selective neuronal vulnerability will all tend to increase this overlap and may make such differentiation difficult. Previous PET studies have attempted to identify ischemic, but viable, cerebral tissue with measurements of rCBF, rCMR02, and regional oxygen extraction fraction (rOEF) (Lenzi et aI., 198 1; Baron et aI. , 1983; Wise et aI., 1983a; Powers et aI., 1985) . These studies remain incon clusive due to methodological problems, small num bers of patients, or because they were performed on subjects with acute ischemic stroke in whom the reversibility of the cerebral damage at the time of PET could not be determined.
The purpose of the present investigation was to determine the minimum rCBF and rCMR02 re quired by the brain to maintain normal function and viability for periods of more than a few hours. PET measurements were performed on a heterogeneous group of 50 patients with varying degrees of cere bral ischemia but no evidence of infarction. These measurements, along with measurements of re gional cerebral blood volume (rCBV) and rOEF, were then compared with measurements from re gions of established cerebral infarction in 10 pa tients. The accuracy of PET measurements for dis tinguishing among normally functioning tissue, non functioning but still viable tissue, and infarcted tissue was determined. Measurements from a total of 702 regions in these 60 subjects were analyzed.
METHODS

Subjects
PET measurements were performed in four different groups of subjects. Group I consisted of 24 normal sub jects aged 18-84 years. Te n were men and 14 were women. Seventeen of the normal subjects were volun teers recruited by public advertisement and were ",;50 years of age and had no history or evidence of neurolog ical disease. The seven remaining normal subjects, aged 68-84 years, were participants in the Washington Uni versity Memory and Aging Project. These subjects were also recruited by public advertisement. Each underwent a clinical interview, general physical and neurological ex amination, standardized 2-h battery of psychological tests, basic blood and urine tests, and a computerized tomography (CT) scan of the brain. Only those classified as normal healthy individuals according to previously published criteria (Berg et aI., 1982) were included in the present study. Group II consisted of 24 patients with known occlusive disease in the carotid circulation. All had normal neurological examinations and normal brain CT scans at the time of PET. Fifteen had had hemispheric transient ischemic attacks, five had had transient mon ocular blindness, and four had asymptomatic carotid bruits. Angiography revealed proximal middle cerebral artery stenosis of 50 and 95% in two patients, internal carotid artery stenosis of >90% in nine patients, and in ternal carotid artery occlusion in the remaining 13 pa tients. These 24 subjects included 11 men and 13 women. They ranged in age from 45 to 76 years. Group III con sisted of two patients who developed reversible ischemic neurological deficits (RIND) as a result of middle cerebral artery vasospasm following aneurysmal subarachnoid hemorrhage. Both were hemiparetic when PET studies were performed. Each went on to make a full neurological recovery when vasospasm resolved. Further details of these two patients have previously been reported (Powers et aI., 1985) . Group IV consisted of 10 patients, aged 35-71 years, with clinically stable cerebral infarcts 8 days to 3 years old. Subjects included six men and four women. All had lucent areas by CT in the cortical territory of the middle cerebral artery that corresponded to well-demar cated areas of decreased rCBF and rCMRO, by PET. Patients in groups I and II were considered to have func tional, viable cerebral tissue. Those in group III were considered to have nonfunctional, but still viable cerebral tissue, and those in group IV were considered to have nonfunctional, nonviable cerebral tissue.
PET measurements
Measurements of regional cerebral hemodynamics and metabolism were performed on the PETT VI tomograph in the low resolution mode. This machine collects seven contiguous tomographic slices 14.4 mm apart, with an intrinsic resolution of 11.7 -13.9 mm in the transverse plane and 9.7-20.5 mm in the axial direction (Ter-Pogos sian et aI., 1982). Patients were positioned so that the lowest tomographic slice was near the canthomeatal line. The head was then immobolized by an individual, heat molded plastic, face mask attached to a head rest. A plastic plate containing seven vertical radioopaque wires corresponding to each of the seven tomographic slices was then attached to the headrest. The exact position of the slices relative to each patient's skull was recorded by a lateral skull x-ray (Fox et aI., 1985) . Calibration of the PETT VI tomograph to achieve quantitative measure ments of local tissue radioactivity was performed as pre viously described (Raichle et aI., 1983) . Venous and ar terial catheters were placed to permit radiotracer injec tion and collection of arterial blood samples.
A transmission scan with a 68Ge/68Ga ring source was performed on each subject to provide data on attenuation of photons necessary for quantitative reconstruction of subsequent scans. Three separate physiological studies were then carried out. During each, sequential arterial blood samples were drawn to permit conversion of the quantitative regional radioactivity data obtained with the tomograph to quantitative physiological measurements. All studies were performed in a darkened room with low ambient noise level. Eyes and ears were not masked. rCBF was measured using bolus intravenous injection of 150-labeled water (Herscovitch et aI., 1983; Raichle et aI., 1983) . rCBV was measured following brief inhalation of air containing trace amounts of 150-labeled carbon mon oxide (Grubb et aI., 1978; Mintun et aI., 1984) . rCMR02 was measured using brief inhalation of 150-labeled ox ygen in combination with data supplied by the preceding rCBF and rCBV studies. This technique directly mea sures the rOEE The rCMR02 is then calculated as the product of rOEF, rCBF, and the arterial oxygen content (Mintun et aI., 1984) . The short half-life (123 s) of 150 permitted all of these studies to be performed in rapid succession. All radionuclides were produced in the Wash ington University cyclotron.
Informed written consent from the subject or next of kin was obtained prior to each PET study. AlI protocols were approved by the Human Studies Committee and the Radioactive Drug Research Committee of the Washington University School of Medicine.
Data analysis
Regional values for the four PET measurements were determined using a stereotactic method for anatomical localization that was recently developed in this laboratory (Fox et aI., 1985) . The stereotactic coordinates of seven 1.37 x 1.37 em (5 x 5 pixel) regions within the cortical territory of the left middle cerebral artery were deter mined from a standard atlas (Talairach et aI., 1967) (Table   I ). These regions were located -1 em deep to the surface of the brain in order to minimize the contribution of met- Coordinates (cm) are for the center of a 1.37 x 1.37 (5 x 5 pixel) region in either hemisphere. Measurements are taken from Talairach et al. (1967) .
R-L, right-left; A-P. anterior-posterior. 1985 abolicalIy inactive cerebrospinal fluid to the PET mea surements. Each region thus contained a variable mixure of cortical gray and subcortical white matter. For each subject, a series of measurements was made on the lateral skulI x-ray and the transmission tomographic scan. These measurements were used to define the relationship be tween the subject's brain and the PET images. With these data, the stereotactic coordinates for each of the seven regions were converted to PET scan coordinates for each individual subject. Using these coordinates, each atlas region was placed on the appropriate PET slice. No re gion was placed on a PET slice >7 mm (one-half the interslice distance) in the vertical plane from its actual anatomic position. Homologous regions in the right hemi sphere, symmetrical about the biparietal midline, were then constructed ( Fig. 1 ). For group I subjects, all 14 regions in each patient were used for analysis, yielding a total of 336 regions. In group II, two regions in one pa tient included part of the lateral sinus (as visualized on the rCBV scan). These were discarded. The remaining 12 regions in this patient and 14 regions in the other patients were used for analysis, yielding a total of 334 regions in group II. In the two group III patients, only the seven regions in the hemisphere contralateral to the hemiparesis were used. In one of these patients, two of these regions included an asymptomatic intracerebral hematoma. These were discarded, yielding a total of 12 regions in two patients. For group IV patients with cortical infarc tion, the standard stereotactic atlas regions were not used. Instead, for each patient, a 5 x 5 pixel region was placed in the middle of the CBF-CMR02 defect on each of two separate slices. All PET defects were larger than the 5 x 5 region, minimizing the partial volume effect from surrounding uninfarcted tissue. These regions were all within the middle cerebral artery distribution and were all approximately the same distance from the inner table of the skull as the standard regions. This yielded a total of 20 regions for the 10 patients. Mean regional values for each of the 60 patients were determined by averaging the regional values of each. The number of regions av eraged per patient thus varied from 14 in group I to 2 in group IV. These mean regional values were compared by one-way analysis of variance (AN OVA) and the Newman Keuls multiple range tests (Zar, 1974) . An ex significance level for the ANOVA was taken at p = 0.05 and adjusted to 0.0125 to compensate for the effect of performing sep arate comparisons for each of the four different PET mea surements (Wallenstein et aI., 1980) . An ex significance level of p = 0.05 was used for the Newman-Keuls test.
RESULTS
Statistical analysis of patient mean values dem onstrated that regions of infarction (group IV) have significantly lower CMR02 and OEF than regions from the other three groups and lower CBF than groups I and II. No significant differences in cere bral blood volume were noted among the four groups ( Table 2) .
The range of regional values from the four study groups are shown in Ta ble 3. As expected, there was great variability in measurements within each group. The minimum rCBF in normal subjects was 30 ml/lOO g-min and the minimum normal rCMROz was 1. 4 ml/lOO g-min. To determine the minimum hemodynamic and metabolic requirements for normal cerebral function, data from group I (normal sUbjects) and group II (carotid occlusive disease with normal CT scan and normal neurological ex amination) were combined. These were compared with the data from subjects with nonfunctioning ce rebral regions (groups III and IV) ( Table 4 ). The minimum rCBF and rCMROz in functional brain were 19 and 1.3 ml/l00 g-min, respectively. There was a good deal of overlap between the measure ments for functional and nonfunctional brain. Forty-seven percent of regions from nonfunctional brain had rCBF values within the functional range, and 53% had rCMROz within the functional range. Measurements of rCBV and rOEF showed an even greater overlap.
The hemodynamic and metabolic requirements for cerebral viability were determined from the combined data of groups I, II, and III. These were compared to infarcted regions from group IV ( Table  5 ). The minimum rCBF and rCMROz observed in viable brain were 15 and 1.3 ml/l00 g-min, respec tively. Again, there was a significant overlap be tween rCBF values, with 60% of the rCBF values from infarcted regions within the viable range. Mea surements of rCMR02 provided much better differ entiation between viable and nonviable tissue, with only 20% of values from infarcted areas within the viable range. rCBV and rOEF values again showed marked overlap.
DISCUSSION
We have used PET to determine the minimum values for CBF and CMR02 associated with cere bral function and viability in 50 subjects. Before the biological implications of our findings are dis cussed, it is necessary to consider several aspects of the methodology used in this study. As with all PET studies, the accuracy of the regional measure ments is greatly influenced by partial volume av eraging due to limited spatial resolution. As a result Newman-Keuls I > II > III = IV I, II, III > IV III > I = II > IV CBF, cerebral blood flow; CMR02, cerebral metabolic rate of oxygen; CBV, cerebral blood volume; OEF, oxygen extraction fraction; n, number of subjects; Y, number of regions; TIA,AB, transient ischemic attacks, asymptomatic bruits; RIND, reversible ischemic neurologic deficit; ANOVA, anal ysis of variance. of this, each regional measurement receives a con tribution from tissue in the surrounding area, as well as tissue actually within that region. We placed our regions far enough away from the surface of the brain and the ventricles to minimize the contribu tion of CSF space. Without doing an explicit cor rection for cerebral atrophy (Herscovitch et aI., 1984) , however, we cannot completely eliminate the effect of differences in sulcal size. We have based our analysis on measurements obtained from dif ferent brain regions within the cortical distribution of the middle cerebral artery. We avoided areas of the brain known to be selectively vulnerable to isch emic damage, such as the hippocampus (Brierly and Graham, 1984) . Our data cannot, therefore, be ex trapolated to other brain regions. We have assumed that ischemic vulnerability of the entire middle ce rebral artery territory is the same. The well-known selective vulnerability of different layers of cortex (Brierly and Graham, 1984) does not invalidate this assumption, as separate cortical layers are well below the resolution of PET. Due to variation in the anatomic location of the PET slices in each indi vidual, the regions used in groups I, II, and III varied somewhat in their actual location. In addi tion, the regions of infarction chosen for group IV were not the same as the regions studied in groups I, II, and III. All regions in all four groups were, however, within the middle cerebral artery territory at a similar depth in the brain. To determine min imum values for flow and metabolism, we sampled seven 1.37 x 1.37 cm stereotactically located re gions from each hemisphere. In doing so, we have only sampled a portion of the middle cerebral artery territory, and, therefore, our estimates of threshold values must be considered to be conservatively high. We have used this stereotactic approach to minimize investigator bias in the choice of regions for analysis. Region locations for these mlllimum value determinations were not based on the physi ological images because this requires subjective de cisions about the location of the surface of the brain and central white matter that cannot be made ac curately. For the two patients in group III, we have chosen to follow the same approach of using stan dard regions rather than to try to decide which cor tical area was primarily responsible for the produc tion of the neurological deficit. As we were inter ested in minimum values, inclusion of other regions in these patients posed no problem.
The present study demonstrates that rCBF � 19 mllIOO g-min is adequate to maintain normal cere bral function and that rCBF �15 ml/IOO g-min is adequate to preserve tissue viability. These findings are remarkably consistent with thresholds for neu ronal function and viability determined by other in vestigators (Leech et aL, 1973; Trojaborg and Boysen, 1973; Sundt et al. , 1974; Jones et aL, 198 1; Astrup, 1982; Heiss and Rosner, 1983; Branston et aL, 1984) . However, our results are not strictly comparable with these other data for two reasons. First, as stated earlier, these previous experiments have investigated the effect of sudden changes in CBF for short periods of time. Our subjects had subacute or chronic causes of ischemia, such as va sospasm or atherosclerosis, which are likely to pro-CMR02 (mIlIOO g min) duce more gradual and prolonged decreases in CBF. Second, and more important, previously deter mined CBF thresholds were based primarily on di rect measurements in gray matter (Marcoux et al. , 1982; Heiss and Rosner, 1983; Branston et aI., 1984) or by techniques that predominantly measure gray flow (Trojaborg and Boysen, 1973; Sundt et aI., 1974) . Threshold values for white matter infarction, when measured, were much lower (Jones et aI. , 198 1; Marcoux et aI. , 1982) . The regions that we have analyzed contain a mixture of both gray and white matter; a fact confirmed by the observation that the mean normal value for CBF from these regions is very close to values for whole brain blood flow measured by the Kety-Schmidt technique (Siesjo, 1978) . As the rCBF we have measured is a weighted average of gray matter and white matter flow, the minimum gray flow associated with cere bral function and viability must be higher than the values of 19 and 15 mlilOO g-min that we have ob served.
We found that rCMR02 values of �1.3 mi/IOO g min were sufficient to sustain normal cerebral func tion. Two patients with nonfunctional, but viable, brain (group III) also had rCMR02 values> 1.3 mll 100 g-min. This is consistent with studies by Kety et al. (1950) and Finnerty et al. (1954) demonstrating that reductions in CBF caused neurological symp- toms prior to any change in whole brain oxygen metabolism. Few studies are available concerning the critical value of rCMR02 necessary to maintain cerebral viability in man. Shalit et al. (1972) mea sured whole brain CMR02 in 24 patients with coma of different etiologies, using a modification of the Kety-Schmidt technique and jugular venous sam pling. Those with reversible coma had CMR02 of 1.4-2.6 mlllOO g-min. Brain death was associated with CMR02 values of �0.6 mlllOO g-min. Two pre vious PET studies of rCMR02 thresholds (Lenzi et aI., 198 1; Baron et aI., 1983) were methodologically flawed by failure to correct for intravascular 15 0_ hemoglobin, resulting in overestimation of rCMR02 (Lammert sma et aI., 1983) . Lenzi et al. (198 1) studied 27 patients with cerebrovascular disease and concluded that the rCMR02 threshold for no recovery was 1-1. 5 mlllOO g-min. The criterion for recovery, as elaborated in a subsequent paper (Lenzi et aI., 1982) , was a marked improvement in general physical status, not the absence of tissue infarction. Baron et al. (1983) measured rCMR02 in 25 patients between 2 and 38 days after completed ischemic stroke. Follow-up CT scans or autopsy were used to define areas of tissue necrosis. All values of rCMR02 <1.5 mlll00 g-min were associ ated with subsequent necrosis. As some of these studies were performed quite early in the course of stroke, it is not clear whether all areas that went on to necrosis were irreversibly damaged at the time of PET. In spite of methodological differences, the results of these three studies are in general agree ment with our own findings that rCMR02 < 1.3 mil 100 g-min is inadequate to sustain tissue viability in humans for prolonged periods of time.
Accurate regional measurements of rCMR02 by PET in areas of cerebral infarction are scarce. In most studies, rCMR02 was overestimated because of failure to correct for radioactivity due to intra vascular IS O-hemoglobin (Baron et aI., 198 1, 1983; Lenzi et aI., 1982) . Wise et al. (1983a) have reported rCMR02 values for nine patients with acute isch emic stroke. Values ranged from �0. 5 to 2. 5 mlllOO g-min. A correction for intravascular IS O-hemo globin is mentioned in this paper, but it is not clear how it was done or whether the correction was per formed for all sUbjects. In a subsequent study of cerebral infarction, Wise et al. (1983b) calculated rCMR02 values using the correction for IS O_he_ moglobin described by . In this study, however, infarcts were defined as areas with an rCMR02 value of <1.5 mlllOO g min and were not independently characterized. Pan tano et al. (1985) have recently reported corrected J Cereb Blood Flow Metabol, Vol. 5, No. 4, 1985 rCMR02 values of 1. 2-1. 9 mlllOO g-min in four ce rebral infarcts 10-45 days old. In our study, regions of cerebral infarction had rCMR02 values (cor rected for intravascular IS O-hemoglobin) ranging from 0.1 to 2. 6 mlll00 g-min, Of the four physio logical variables measured, rCMR02 showed the least overlap between areas of infarction and re gions with viable cerebral tissue. Eighty percent (16 of 20) of infarcted regions in 8 of the 10 patients showed rCMR02 values below the minimum value for viable tissue of 1.3 mlllOO g-min.
Even though regional oxygen extraction fraction was significantly lower in patients with infarction, it did not prove to be of value in differentiating vi able from nonviable tissue due to the wide vari ability of measurements among the four groups.
We found significant overlap between measure ments of rCBF and rCMR02 in regions of cerebral infarction and in regions of viable tissue. This un doubtedly reflects methodological variability, as well as the complex pathophysiology of ischemia and infarction. We intentionally chose a heteroge neous group of patients to study, in order to deter mine the value of rCBF and rCMR02 measurements under varied pathological conditions. The presence of late luxury perfusion in several of the established infarcts in this series no doubt contributed to the poor discrimination between infarcted and viable tissue provided by measurements of rCBF. Early postischemic hyperemia would be expected to pro duce the same effect in patients with more acute infarcts (Olsen et aI., 198 1; Pulsinelli et aI., 1982) . The influence of other factors, such as variations in antecedent cerebral glucose stores (Myers and Ya maguchi, 1977) or the effect of subarachnoid blood itself (group III), certainly contributed to our in ability to identify absolute threshold values that separated infarcted from noninfarcted tissue.
We have demonstrated that quantitative PET measurements of rCMR02 can distinguish between viable cerebral tissue and established cerebral in farction. Extension of these findings to the care of patients with acute ischemic stroke will require fur ther study. We hypothesize that acutely ischemic regions of brain with rCMR02 <1.3 mlll00 g-min are irreversibly infarcted. Those with values above this have adequate oxidative metabolism to pre serve neuronal viability and are thus potentially sal vageable. This hypothesis can be tested only by acutely reestablishing flow to these areas and de termining if cerebral function and viability are pre served. We are currently investigating patients with cerebral vasospasm due to subarachnoid hemor rhage as a naturally occurring model of reversible ischemia. Early results support our hypothesis (Powers et aI., 1985) . These patients are not ideal candidates for study, however, as reperfusion is variable and dependent on the natural course of va sospasm. A reliable method for reperfusing low flow areas in acute ischemic stroke would be far superior. Surgical revascularization is not always feasible due to the presence of middle cerebral ar tery branch occlusions in many of these patients (Bladin, 1964; Fieschi and Bozzao, 1969; Castaigne et aI., 1970) . A safe and easily administered throm bolytic agent would be ideal. Tissue-type plasmin ogen activator (van der Werf et aI., 1984) may prove to be suitable for this purpose.
